Friday, August 29, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

InMode Reports Strong Financial Performance and Market Reaction

Elaine Mendonca by Elaine Mendonca
February 13, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 13, 2024, InMode unveiled its impressive financial performance for the fourth quarter and full year of 2023. The company achieved remarkable success, recording a GAAP net income of $55.2 million, equivalent to $0.64 per diluted share during Q4 2023. This demonstrated significant growth compared to the same period the previous year, where they reported $37.7 million, or $0.44 per diluted share.

In addition to their outstanding earnings, InMode confidently projected their full-year earnings for 2024. They anticipate earnings per share to range between $2.53 and $2.57, accompanied by a robust revenue forecast ranging from $495 million to $505 million. These figures underscore the company’s unwavering commitment to sustained financial success.

However, despite these impressive results, the market’s reaction has been less favorable, resulting in a decline in InMode’s share price. This reaction is likely a temporary setback as investors adjust their expectations based on the company’s future prospects. InMode remains steadfast in its dedication to innovation and growth, ensuring its continued success in the dynamic market landscape.

InMode Ltd. (INMD) Stock Performance Plummets by 6.64%: Analysis and Outlook for Future Performance

On February 13, 2024, InMode Ltd. (INMD) experienced a significant decline in its stock performance. The stock witnessed a drop of $1.76 since the market last closed, representing a substantial 6.64% decline. INMD opened at $24.00, $2.49 lower than its previous close, suggesting negative sentiment carried over from the previous trading session. The stock was trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a lack of positive price momentum. Investors and market participants will closely monitor INMD’s future performance and consider other fundamental factors to gain a comprehensive understanding of the stock’s outlook.

INMD Stock: Decline in Total Revenue and Net Income Raises Concerns

On February 13, 2024, INMD stock experienced a decline in both total revenue and net income. The data, sourced from CNN Money, reveals that INMD’s total revenue for the past year stood at $454.27 million, while it recorded $123.11 million in the third quarter. Comparing these figures to the previous year and quarter, we observe a 27.05% increase in total revenue since last year, but a 9.53% decrease since the last quarter.

Similarly, INMD’s net income for the past year amounted to $161.52 million, with $46.52 million in the third quarter. Comparing these figures to the previous year and quarter, we observe that the net income has remained relatively flat since last year, while it has decreased by 16.52% since the last quarter.

The earnings per share (EPS) for INMD stock stood at $1.89 for the past year and $0.56 for the third quarter. Comparing these figures to the previous year and quarter, we find that the EPS has held flat since last year, but has decreased by 16.82% since the last quarter.

The decline in both total revenue and net income on February 13, 2024, indicates a challenging period for INMD stock. While the total revenue had shown growth compared to the previous year, the decrease in revenue since the last quarter suggests a recent downturn in the company’s performance.

Similarly, the net income figures, which remained relatively flat since last year, experienced a significant decline since the last quarter. This decline in net income could be attributed to various factors such as increased expenses, changes in market conditions, or other internal or external factors affecting the company’s profitability.

Furthermore, the decrease in earnings per share since the last quarter indicates a decline in the company’s profitability per outstanding share. This decrease in EPS could be a cause for concern for investors, as it suggests a potential decline in the company’s overall financial health.

It is crucial for investors and stakeholders to closely monitor INMD’s financial performance and evaluate the reasons behind the decline in revenue, net income, and EPS. Additionally, it would be prudent to assess the company’s future growth prospects, competitive landscape, and any upcoming developments or strategies that may impact its performance.

Investing in the stock market always carries a certain level of risk, and fluctuations in financial performance are a common occurrence. Therefore, it is recommended that investors seek professional financial advice and conduct thorough research before making any investment decisions.

Tags: INMD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biochemistry and biomedicines

JetBlue Airways Stock Soars Amidst Carl Icahns Investment and Merger Controversy

Partnerships

Brighthouse Financials Q4 Financial Results Fall Below Expectations

Technology Robotics Trading online

Beamr Imaging Ltd Surges on Collaboration with Nvidia and Launch of Video Cloud Service

Recommended

Biopharmaceutical Markets and money (1)

Robinson Brothers Enhances Drug Testing with Intelligent Fingerprinting System

2 years ago
WM stock news

The title for this article could be: First Trust Direct Indexing Reduces Stake in Spotify Technology, Impacting Market Capitalization

2 years ago
Beam Therapeutics Inc Stock

Can Beam Therapeutics Stock Recover From Its Downturn?

6 days ago
Finance_Fiscal (3)

Analyst Initiates Coverage on GoodRx Holdings with Outperform Rating and 8 Price Target

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB Adobe ADSK ALB AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DELL DIS DWAC Eli Lilly GM IBM INTC Intel LLY META Micron MP Materials MSFT NFLX NIO NVDA NVO Oracle Palantir PARA PLTR Red Cat Robinhood SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Institutional Investors Bet Big on MFA Financial’s Hidden Value

Atlanticus Defies Fintech Profitability Challenges with Robust Growth and Dividend

Unisys: The Overlooked Infrastructure Play in the AI Gold Rush

SunHydrogen Shares Surge on Unexplained Trading Activity

The Quiet AI Powerhouse: Broadcom’s Strategic Ascent

D-Wave Quantum Receives Massive Price Target Boost Following Exceptional Performance

Trending

CME Stock
Stocks

CME Group Emerges as the Dominant Force in Institutional Crypto Derivatives

by Robert Sasse
August 29, 2025
0

While retail attention remains fixed on Bitcoin and Ethereum spot prices, a significant shift is occurring behind...

Tilray Stock

Tilray Stock Navigates Billion-Dollar Losses Amid Strategic Expansion

August 29, 2025
Polestar Auto.adr/a Stock

Polestar’s Mid-Year Report: A Crucial Test for the Electric Vehicle Maker

August 29, 2025
MFA Stock

Institutional Investors Bet Big on MFA Financial’s Hidden Value

August 29, 2025
Atlanticus Stock

Atlanticus Defies Fintech Profitability Challenges with Robust Growth and Dividend

August 29, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • CME Group Emerges as the Dominant Force in Institutional Crypto Derivatives August 29, 2025
  • Tilray Stock Navigates Billion-Dollar Losses Amid Strategic Expansion August 29, 2025
  • Polestar’s Mid-Year Report: A Crucial Test for the Electric Vehicle Maker August 29, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com